Maria Berkman is a Partner at Vensana Capital. Maria brings over 20 years of venture, clinical, and consulting experience to Vensana. Prior to Vensana, Maria was the Head of MedTech at Broadview Ventures and Managing Director of Longview Ventures – affiliate funds dedicated to early-stage investments in cardiovascular disease and stroke. Maria currently serves on the boards of Alleviant Medical and Vensana Innovation and previously served as Chair of AtaCor Medical (partnered with Abbott), and on the boards of Apama (acquired), CardiAQ (acquired), Remedy Therapeutics (acquired), Vectorious (acquired), Capricor (IPO), and Lyra Therapeutics (IPO). Prior to her venture career, Maria was a management consultant with Monitor Group and trained at Mass General Brigham’s Newton Wellesley Hospital. She concurrently earned an MD from the UCLA School of Medicine and an MBA from the Anderson School of Management at UCLA.